Niemann-Pick Type A PerlQuest
“Perlara’s unique drug discovery platform and business model is a perfect fit for advancing our efforts in discovering existing compounds that can be repurposed, and new novel compounds that can be optimized for treating Niemann-Pick Type A,”
Steven Laffoon
Co-Founder and President of Wylder Nation Foundation
Our Progress
Stage 3 screening of discovery library on nematode model underway.
![](https://www.perlara.com/wp-content/uploads/PerlQuest-NPA-Timeline-9.3.19-950x398px-v1.png)